A Study of AR-12286 in Patient With Elevated Intraocular Pressure (IOP)
Public ClinicalTrials.gov record NCT00902200. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 Ophthalmic Solution 0.05%, 0.1% and 0.25% in Patients With Elevated Intraocular Pressure
Study identification
- NCT ID
- NCT00902200
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Aerie Pharmaceuticals
- Industry
- Enrollment
- 89 participants
Conditions and interventions
Conditions
Interventions
- AR-12286 Drug
- AR-12286 vehicle Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2009
- Primary completion
- Aug 31, 2009
- Completion
- Aug 31, 2009
- Last update posted
- Apr 20, 2014
2009
United States locations
- U.S. sites
- 8
- U.S. states
- 6
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Soilsh Practice | Pasadena | California | 91105 | — |
| Bacharach practice | Petaluma | California | 94954 | — |
| Hernando Eye Institute | Brooksville | Florida | 34613 | — |
| Taustine Eye Center | Louisville | Kentucky | 40217 | — |
| Mundorf Practice | Charlotte | North Carolina | 28204 | — |
| Black Hills Regional Eye Institute | Rapid City | South Dakota | 57701 | — |
| Texan Eye | Austin | Texas | 78731 | — |
| Medical Center Ophthalmology Associates | San Antonio | Texas | 78240 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00902200, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 20, 2014 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00902200 live on ClinicalTrials.gov.